An open-label, dose-escalating study of the pharmacokinetics, safety and tolerability of fesoterodine in pediatric overactive bladder patients aged 11-17 years
|Effective start/end date||2/18/09 → 12/31/10|
- PFIZER, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.